跳至主要内容
临床试验/IRCT20180804040694N1
IRCT20180804040694N1招募中3 期

Effect of a topical Boswellia-based cream (Persian Medicine product) on skin manifestations and quality of life in mild to moderate plaque psoriasis

Tehran University of Medical Sciences0 个研究点目标入组 108 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
108

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Diagnosed with clinical of mild to moderate Plaque Psoriasis
  • Age between 18-70 years old
  • PASI score <12
  • Involvement of body surface area <10%
  • Written informed consent

排除标准

  • Gguttate, erythrodernic, psoriatic arthritis or pustular psoriasis at the time of screening; psoriasis vulgaris patients with face involvement only;
  • Known allergic or hypersensitive reactions to cream components;
  • Using medications that could trigger psoriasis like beta blockers, antimalarials, terbinafine, calcium channel blockers, interleukins and lithium;
  • Previous treatment with systemic corticosteroids, biologic and immunosuppression drugs or psoralen ultraviolet A therapy within the previous four weeks;
  • Previous treatment with local corticosteroids within the previous two weeks;
  • Presence of skin infections or malignancy in the treatment area;
  • Severe psoriasis;
  • Patients who require systemically acting medications for the treatment of psoriasis;
  • Pregnant or breast-feeding females;

研究者

相似试验

Effect of Boswellia in psoriasis | 临床试验